CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Primary antibody deficiency in a tertiary referral hospital: A 30-year experiment
Authors
H. Abolhassani
M. Afarideh
+36 more
A. Aghamohammadi
H. Ahanchian
A. Ahmadiafshar
S. Aleyasin
R. Amin
M. Bemanian
Z. Chavoushzadeh
T. Cherghi
R. Faridhosseini
A. Fayezi
J. Ghaffari
A. Ghajar
M. Gharagozlou
A. Havaei
F. Jabbari-Azad
N. Kalantari
H.A. Khazaei
A. Mahdaviani
S.N. Masoom
B. Mirminachi
B. Mirsaeed-Ghazi
M. Moghtaderi
J. Mohammadi
P. Mohammadinejad
I. Mohammadzadeh
M. Movahedi
M. Nabavi
N. Parvaneh
S. Pourhamdi
N. Rezaei
B. Sadeghi
M. Sadeghi-Shabestari
A. Shafiei
R. Sherkat
F. Zandieh
M. Zandkarimi
Publication date
1 January 2015
Publisher
Abstract
Background: Primary antibody deficiency (PAD) is the most common group of primary immunodeficiency disorders (PID), with a broad spectrum of clinical features ranging from severe and recurrent infections to asymptomatic disease. Objectives: The current study was performed to evaluate and compare demographic and clinical data in the most common types of PAD. Materials and Methods: We performed a retrospective review of the medical records of all PAD patients with a confirmed diagnosis of common variable immunodeficiency (CVID), hyper IgM syndrome (HIgM), selective IgA deficiency (SIgAD), and X-linked agammaglobulinemia (XLA) who were diagnosed during the last 30 years at the Children�s Medical Center, Tehran, Iran. Results: A total number of 280 cases of PAD (125 CVID, 32 HIgM, 63 SIgAD, and 60 XLA) were enrolled in the study. The median (range) age at the onset of disease in CVID, HIgM, SIgAD, and XLA was 2 (0-46), 0.91 (0-9), 1 (0-26), and 1 (0-10) years, respectively. Gastrointestinal infections were more prevalent in CVID patients, as were central nervous system infections in XLA patients. Autoimmune complications were more prevalent in HIgM patients, malignancies in CVID patients, and allergies in SIgAD patients. The mortality rate for CVID, HIgM, and XLA was 27.2, 28.1, and 25, respectively. No deaths were reported in SIgAD patients. Conclusions: SIgAD patients had the best prognosis. While all PAD patients should be monitored for infectious complications, special attention should be paid to the finding of malignancy and autoimmune disorders in CVID and HIgM patients, respectively. © 2015 Esmon Publicidad
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Golestan University of Medical Sciences Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.goums.ac.ir:4830
Last time updated on 11/11/2016
eprints Iran University of Medical Sciences
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.iums.ac.ir:5807
Last time updated on 10/10/2019